MDxHealth (R) : MDxHealth annonce la présentation des données positives de SelectMDx et de ConfirmMDx dans le diagnostic du cancer de la prostate

NEXT STORY
Immunicum AB (publ) Year-End Report 2018
PREV STORY
Orion’s and Bayer’s darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections

author_avatar
NASDAQ Market News

Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology/Technique, Application, End User), Impact of COVID-19, Size, Share, Major Deals & Key Players Analysis – Forecast to 2027

author_avatar
NASDAQ Market News

Replimune Reports Fiscal Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News